Unsere Publikationen (Auswahl)

2011

Bishop D, Nikić I, Brinkoetter M, Knecht S, Potz S, Kerschensteiner M, Misgeld T. Near-infrared branding efficiently correlates light and electron microscopy. Nat Methods  8:568-70 (2011)

Gilley J, Seereeram A, Ando K, Mosely S, Andrews S, Kerschensteiner M, Misgeld T, Brion JP, Anderton B, Hanger DP, Coleman MP. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. Neurobiol Aging   [Epub ahead of print] (2011)

Bareyre FM, Garzorz N, Lang C, Misgeld T, Büning H, Kerschensteiner M. In vivo imaging reveals a phase-specific role of STAT3 during central and peripheral nervous system axon regeneration. Proc Natl Acad Sci U S A 108:6282-7 (2011)

Nikić I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, Bareyre FM, Brück W, Bishop D, Misgeld T, Kerschensteiner M. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med. 17:495-9 (2011)

2010 

Fieni F, Parkar A, Misgeld T, Kerschensteiner M, Lichtman JW, Pasinelli P, Trotti D. Voltage-dependent inwardly rectifying potassium conductance in the outer membrane of neuronal mitochondria. J Biol Chem.  285:27411-7 (2010)

Kerschensteiner M, Meinl E, Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Results Probl Cell Differ. 51:197-216 (2010)

2009

Adalbert R, Nogradi A, Babetto E, Janeckova L, Walker SA, Kerschensteiner M, Misgeld T & Coleman MP. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain 132:402-16 (2009)

Kerschensteiner M, Meinl E & Hohlfeld R. Neuro-immune cross-talk in CNS diseases. Neuroscience 158:1122-32 (2009)

2008

Kerschensteiner M, Reuter MS, Lichtman JW & Misgeld T. Ex vivo imaging of motor axon dynamics in murine triangularis sterni explants. Nature Protocols 3:1645-53 (2008)

Schubert T, Kerschensteiner D, Eggers ED, Misgeld T, Kerschensteiner M, Lichtman JW, Lukasiewicz PD & Wong RO. Development of presynaptic inhibition onto retinal bipolar cell axon terminals is subclass-specific. Journal of Neurophysiology 100:304-16 (2008).

Bareyre FM. Neuronal repair and replacement in spinal cord injury. Journal of the Neurological Sciences 265(1-2):63-72 (2008)

2007

Misgeld T, Kerschensteiner M, Bareyre FM, Burgess RW & Lichtman JW. Imaging axonal transport of mitochondria in vivo. Nature Methods 4:559-61 (2007)

Marklund N, Bareyre FM, Royo NC, Thompson HJ, Mir AK, Grady MS, Schwab ME & McIntosh TK. Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. Journal of Neurosurgery 107:844-53 (2007)

Hohlfeld R, Kerschensteiner M & Meinl E. Dual role of inflammation in CNS disease. Neurology 68:S58-63 (2007)

Misgeld T, Nikic I & Kerschensteiner M. In vivo imaging of single axons in the mouse spinal cord. Nature Protocols 2:263-8 (2007)

2006

Misgeld T & Kerschensteiner M. In vivo imaging of the diseased nervous system. Nature Reviews Neuroscience 7:449-63 (2006)

Merkler D, Ernsting T, Kerschensteiner M, Brück W & Stadelmann C. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 129:1972-83 (2006)

Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H & Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.  Neurological Sciences Supp1:S1-7. (2006)

2005

Bareyre FM, Kerschensteiner M, Misgeld T & Sanes JR. Transgenic labeling of the corticospinal tract for monitoring axonal responses to spinal cord injury. Nature Medicine 11:1355-60 (2005)

Kerschensteiner M, Schwab ME, Lichtman JW & Misgeld T. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nature Medicine 11:572-7 (2005)

McCann CM, Bareyre FM, Lichtman JW & Sanes JR. Peptide tags for labeling membrane proteins in live cells with multiple fluorophores. Biotechniques 38:945-52 (2005)

Lenzlinger PM, Shimizu S, Marklund N, Thompson HJ, Schwab ME, Saatman KE, Hoover RC, Bareyre FM, Motta M, Luginbuhl A, Pape R, Clouse AK, Morganti-Kossmann C & McIntosh TK. Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats. Neuroscience 134:1047-56 (2005)

2004

Bareyre FM, Kerschensteiner M, Raineteau O, Mettenleiter TC, Weinmann O & Schwab ME. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nature Neuroscience 7:269-77 (2004)

Kerschensteiner M, Bareyre FM, Buddeberg BS, Merkler D, Stadelmann C, Brück W, Misgeld T & Schwab ME. Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. Journal of Experimental Medicine 200(8):1027-38 (2004)

Buddeberg BS, Kerschensteiner M, Merkler D, Stadelmann C & Schwab ME. Behavioral testing strategies in a localized animal model of multiple sclerosis. Journal of Neuroimmunolology 153:158-70 (2004)

Lenzlinger PM, Saatman KE, Hoover RC, Cheney JA, Bareyre FM, Raghupathi R, Arnold LD & McIntosh TK Inhibition of vascular endothelial growth factor receptor (VEGFR) signaling by BSF476921 attenuates regional cerebral edema following traumatic brain injury in rats. Restorative Neurology and Neuroscience 22:73-9 (2004)

Kerschensteiner M, Stadelmann C, Buddeberg BS, Merkler D, Bareyre FM, Anthony DC, Linington C, Brück W & Schwab ME. Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. American Journal of Pathology 164:1455-69 (2004)